A Phase II/III Study of Sargramostim
Clinical trial NCT04642950 · COMPLETED
Trial details
- NCT number
- NCT04642950
- Sponsor
- Nobelpharma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2021-10-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.